WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Inc Stock Ownership - Who owns Bicara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ivan HyepChief Financial Officer2026-05-219,200$3.79
$34.87kBuy
Ivan HyepChief Financial Officer2026-05-219,200$20.42
$187.88kSell
Claire MazumdarChief Executive Officer2026-05-1812,022$19.96
$239.98kSell
Claire MazumdarChief Executive Officer2026-05-1815,000$3.79
$56.85kBuy
Claire MazumdarChief Executive Officer2026-05-182,978$20.35
$60.60kSell
Ryan CohlheppPresident and COO2026-05-158,000$3.79
$30.32kBuy
Ryan CohlheppPresident and COO2026-05-154,500$20.29
$91.31kSell
Ryan CohlheppPresident and COO2026-05-158,000$20.29
$162.34kSell
David RabenChief Medical Officer2026-04-275,500$22.88
$125.83kSell
David RabenChief Medical Officer2026-04-275,500$3.79
$20.85kBuy

1 of 12

BCAX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCAX insiders and whales buy or sell their stock.

BCAX Shareholders

What type of owners hold Bicara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP11.04%7,255,993$157.38MInstitution
T Rowe Price Investment Management Inc10.05%6,605,780$143.28MInstitution
Kiran Mazumdarshaw9.59%6,297,854$136.60MInsider
Siren LLC8.83%5,802,970$125.87MInstitution
Biocon Ltd8.41%5,523,897$119.81MInsider
Vestal Point Capital LP8.26%5,425,000$117.67MInstitution
Deep Track Capital LP6.18%4,062,500$88.12MInstitution
Janus Henderson Group PLC5.08%3,339,218$72.43MInstitution
Red Tree Management LLC4.83%3,170,509$68.77MInstitution
Tpg GP A LLC4.58%3,010,425$65.30MInstitution

1 of 3

BCAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCAX77.11%22.89%Net BuyingNet Buying
AVBP80.88%19.12%Net Selling
KALV63.55%36.45%Net SellingNet Selling
ATAI27.07%32.65%Net BuyingNet Buying
ARDX42.57%57.43%Net BuyingNet Selling
View Top Biotech Stocks

Bicara Therapeutics Stock Ownership FAQ

Who owns Bicara Therapeutics?

Bicara Therapeutics (NASDAQ: BCAX) is owned by 108.46% institutional shareholders, 32.19% Bicara Therapeutics insiders, and 0.00% retail investors. Kiran Mazumdarshaw is the largest individual Bicara Therapeutics shareholder, owning 6.30M shares representing 9.59% of the company. Kiran Mazumdarshaw's Bicara Therapeutics shares are currently valued at $136.60M.

If you're new to stock investing, here's how to buy Bicara Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.